Evidence map›Paper›PMID 23623449›Full record

Trial reportPsychiatry research2013

Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy.

Shaun M Eack, Raquelle I Mesholam-Gately, Deborah P Greenwald, Susan S Hogarty, Matcheri S Keshavan

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychiatry research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Cognitive enhancement interventions are effective for schizophrenia: why not provide them early?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  6. Cognitive dysfunction and disability in people living with schizophrenia.Journal of family medicine and primary care · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shaun M EackSchool of Social Work, University of Pittsburgh, 2117 Cathedral of Learning, Pittsburgh, PA 15260, USA. sme12@pitt.edu
Raquelle I Mesholam-Gately
Deborah P Greenwald
Susan S Hogarty
Matcheri S Keshavan
University of Pittsburgh · USMassachusetts Mental Health Center · US

Funding

University of Pittsburgh Clinical and Translational Science InstitutionKL2RR024154 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$22.2M
University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
Brain Imaging, Cognitive Enhancement and Early SchizophreniaR01MH092440 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KESHAVAN, MATCHERI S. · 2012 to 2016
$3.1M
Rehabilitation, Brain Function and Early SchizophreniaR01MH060902 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KESHAVAN, MATCHERI S. · 2001 to 2005
$2.7M
Social-Cognitive Rehabilitation and Brain Function in Early SchizophreniaK23MH095783 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EACK, SHAUN M · 2012 to 2015
$629k
Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaR21DA030763 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EACK, SHAUN M · 2010 to 2011
$411k
NCATS NIH HHS KL2 TR000146NCRR NIH HHS K12 RR024154NCRR NIH HHS KL2 RR024154NCRR NIH HHS RR 24154NIDA NIH HHS DA30763NIDA NIH HHS R21 DA030763NIMH NIH HHS K23 MH095783NIMH NIH HHS MH60902NIMH NIH HHS MH 92440NIMH NIH HHS MH95783NIMH NIH HHS R01 MH060902NIMH NIH HHS R01 MH092440
6 · The paper itself

Abstract

Cognitive rehabilitation has shown beneficial effects on cognition in patients with schizophrenia, which may also help to improve negative symptoms due to overlapping pathophysiology between these two domains. To better understand the possible relationship between these areas, we conducted an exploratory analysis of the effects of Cognitive Enhancement Therapy (CET) on negative symptoms. Early course schizophrenia outpatients (n=58) were randomized to 2 years of CET or an Enriched Supportive Therapy (EST) control condition. Results revealed significant and medium-sized (d=0.61) differential improvements favoring CET in overall negative symptoms, particularly social withdrawal, affective flattening, and motor retardation. Neurocognitive improvement was associated with reduced negative symptoms in CET, but not EST patients. No relationships were observed between improvements in emotion processing aspects of social cognition, as measured by the Mayer-Salovey-Caruso Emotional Intelligence Test, and negative symptoms. CET represents an effective cognitive rehabilitation intervention for schizophrenia that may also have benefits to negative symptoms. Future studies specifically designed to examine negative symptoms during the course of cognitive rehabilitation are needed.

Indexed as

Schizophrenic PsychologyCognition DisordersCognitive Behavioral TherapyFemaleHumansLongitudinal StudiesMaleNeuropsychological TestsPsychiatric Status Rating ScalesSchizophreniaSocial BehaviorTreatment OutcomeCognitive rehabilitationNegative symptomsNeurocognitionPsychosocial treatmentSchizophreniaSocial cognition

Identifiers

PMID23623449
PMCPMC3732574
OpenAlexW2054411881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.